Melasma: Clinical Trials

4 trials for Melasma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4
Phase 32Unknown 2

Follow Melasma: new trials by email Literature Review of Melasma trials Research Report on Melasma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tranexamic Acid With Microneedling in Melasma
Hyaluronic acid combined with tranexamic acid microneedling, tranexamic acid microneedling - Melasma
Phase 2UnknownZagazig University272023-06-012023-06-18
Comparison Of Efficacy Of Combination Of TAM Formula Vs Kligman Formula For Melasma.
TAM formula (hydroquinone 2%, tretinoin 0.05% and 5% vitamin C), Kligman formula (hydroquinone 4%, fluocinolone acetonide 0.01% and tretinoin 0.05%) - Melasma
Phase 2UnknownJinnah Postgraduate Medical Centre1222022-08-012023-08-28
Evaluation of Laser and Tranexamic Acid in Treatment of Melasma
Tranexamic acid - Melasma
Phase 2 / Phase 3UnknownAssiut University402020-12-012020-10-22
Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma
Iontophoresis, Azelaic acid cream - Melasma
Phase 2 / Phase 3UnknownMedical University of Vienna702009-01-012010-07-15

Narrower conditions

Melanosis (4)

Broader conditions

Hyperpigmentation (4)  ·  Pigmentation Disorders (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)

Interventions

Ascorbic Acid (1)  ·  Fluocinolone Acetonide (1)  ·  Iontophoresis (1)  ·  Lasers (1)  ·  Percutaneous Collagen Induction (1)  ·  Tranexamic Acid (1)  ·  Tretinoin (1)  ·  hydroquinone (1)

Sponsors

Assiut University (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Medical University of Vienna (1)  ·  Zagazig University (1)

Countries

Austria (1)  ·  Pakistan (1)

Top investigators

JB Schmidt, MD (1)  ·  Oliver Schanab, MD (1)